You searched for Antibody candidate - Page 22 of 69

argenx agx115 abbvie immunooncology biotech deal ucl cancer pharma

News and Trends 21 Apr 2016

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

…(another Belgian biotech) approaches antibody engineering, well known for its Camelidae mAbs. argenx has several propietary antibody platforms. The SIMPLE Antibody uses llama to…make Pharma. (Source: argenx) ARGX-115 is argenx’s…

April 21, 2016 - 2 minutesmins - By Dani Bancroft

leo pharma astrazeneca dermatology biologics

News and Trends 4 Jul 2016

Danish Pharma enters in the Biologics arena with Antibody Buy-out

…AstraZeneca, that are significantly closer to the market. First, there is tralokinumab, which has completed Phase II trials for atopic dermatitis. The candidate is a monoclonal antibody and targets a…

July 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

capella biosciences medicxi ventures advent life sciences osage university partners mabs monoclonal antibodies oncology autoimmune target biology

News and Trends 10 Mar 2016

Antibody Start-up Gets a Slice of a Rebranded €210M Life Sciences Fund

Capella Biosciences (UK) is a life sciences start-up specializing in antibodies. It has just raised an additional €14.3M in a Series A round to develop their antibody pipeline to clinical…

March 10, 2016 - 2 minutesmins - By Denise Neves Gameiro

In Depth 30 May 2024

Covalent biologics: a new class of drugs on the horizon

…American company Enlaza Therapeutics’ undisclosed preclinical pipeline is mainly focused on antibody drug conjugates (ADCs). These drugs consist of an antibody that attaches to cancer cell targets, a chemotherapy drug…

May 30, 2024 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 13 Feb 2020

French Partnership Deploys AI for Antibody Drug Discovery

…development — will help users identify a therapeutic target and select a candidate antibody that can enter production. OSE Immunotherapeutics hopes to deploy the partnership on fusion protein technology called…

February 13, 2020 - 2 minutesmins - By External Contributor

News and Trends 20 Jun 2023

Clearance for anti-tumor bispecific antibody trial

TG ImmunoPharma Co., Ltd. (TGI), which focuses on the development of novel immuno-oncology therapies, says the FDA has granted clearance for the clinical trial of TGI-6, its bispecific antibody. TGI-6…

June 20, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 15 Nov 2022

Biotheus enters agreement with Hansoh Pharma for bispecific antibody

…EGFR/MET bispecific antibody (also known as PM1080) in China, Hong Kong, Macao and Taiwan. Under the terms of the agreement, Hansoh will be granted by Biotheus the exclusive rights to…

November 15, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Oct 2016

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

…(ADCT) is a Swiss Biotech that develops antibody-drug conjugates (ADCs) for oncology applications. Its founder Auven Therapeutics and its partner AstraZeneca have participated in the biggest funding round of the…

October 19, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 5 Jun 2017

What Lies Ahead in Biotech for the UK’s Top Academic Entrepreneur?

…company, Cambridge Antibody Technology (CAT), would go on to be the biggest success story in UK biotech after its team discovered the blockbuster therapeutic antibody, Humira, and became part of…

June 5, 2017 - 7 minutesmins - By Evelyn Warner

antibody drug conjugate adc small cancer treatment

News and Trends 12 Jan 2023

Ajinomoto and Exelixis to discover and develop novel ADCs to treat cancer

…Ajinomoto Co.’s proprietary site-specific bioconjugation and stable linker technologies compatible with commonly used antibody isotypes. AJICAP technology includes its “off-the-shelf” feature, allowing any therapeutic antibody at any stage of development…

January 12, 2023 - 2 minutesmins - By Jim Cornall

Interview 29 May 2017

Meet the Founder of the UK’s Best Biotech that Discovered Humira

…Antibody Technology (CAT), would go on to be the biggest success story in UK biotech after it discovered the blockbuster therapeutic antibody, Humira, and became part of AstraZeneca in 2006…

May 29, 2017 - 9 minutesmins - By Evelyn Warner

ADCs that deliver: The secret lies in rigorous characterization

Antibody-drug conjugates (ADCs) represent an innovative class of potent anti-cancer agents. They combine the specificity of a monoclonal antibody with the potency of a cytotoxic drug, enabling targeted killing of…

September 17, 2024 - 7 minutesmins - By Ute Boronowsky

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

Danish Pharma enters in the Biologics arena with Antibody Buy-out

Antibody Start-up Gets a Slice of a Rebranded €210M Life Sciences Fund

Covalent biologics: a new class of drugs on the horizon

French Partnership Deploys AI for Antibody Drug Discovery

Clearance for anti-tumor bispecific antibody trial

Biotheus enters agreement with Hansoh Pharma for bispecific antibody

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

What Lies Ahead in Biotech for the UK’s Top Academic Entrepreneur?

Ajinomoto and Exelixis to discover and develop novel ADCs to treat cancer

Meet the Founder of the UK’s Best Biotech that Discovered Humira

ADCs that deliver: The secret lies in rigorous characterization

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!